Organization | Piedmont Hospital

Piedmont Hospital Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial

2006

NCT00394524

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2009

Timeline

NOW

Now

Alternative names

Piedmont Hospital, Atlanta | Piedmont Hospital, Atlanta, GA | Piedmont Hospital Research Institute

Active Ingredients

Drugs in Phase 4 Trials (3)

acetylsalicylic acid (aspirin) (1 trial)

clopidogrel (plavix) (1 trial)

prasugrel (effient) (1 trial)

Drugs in Phase 2 Trials (6)

cisplatin (platinol) (1 trial)

docetaxel (taxotere) (1 trial)

Filgrastim (neupogen) (1 trial)

fluorouracil (efudex) (1 trial)

leucovorin (1 trial)

sargramostim (leukine) (1 trial)

Drugs in Other Trials (2)

insulin glulisine (Apidra) (1 trial)

insulin human (humulin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Adenocarcinoma (Phase 2)

Coronary Artery Disease (Phase 4)

Esophageal Neoplasms (Phase 2)

Stomach Neoplasms (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 3
# of Trial APIs: 11